A look into AI and blockchain for drug retailers
In chain drug today, there are few terms that are as buzz-worthy as artificial Intelligence (AI) and blockchain.
Bill Schiffner
Creating a buzz in the supply chain
Technology is playing a big role in the supply chain and how important data is collected and shared. One of the top companies in this area is SupplyHive.
Two unique and poppable confections from SweeTARTS feature multiple flavors and colors
SweeTARTS is launching one-of-a-kind, bite-sized confections inspired by two of its best-selling product lines: SweeTARTS Soft & Chewy Ropes and SweeTARTS Mini Chewy.
For American patients to be put first, DIR fee relief is essential
The following was a post Monday from NACDS president and chief executive officer Steven Anderson on Medium urging action on DIR fee relief in final Medicare rule: We may be just days from learning whether a pending Medicare rule will provide relief from pharmacy direct and indirect remuneration (DIR
Contextualizing the value of retail Rx
A quarter century ago, it was unusual to have flu shots and other vaccinations administered in a retail pharmacy setting.
How to get out from the suffocating miasma of DIR fees
The direct and indirect remuneration (DIR) component of Medicare Part D programs today is very complicated and has been implemented in a variety of ways. The lack of clarity, fairness and transparency to all parties has created business challenges for pharmacies.
Consumers embrace new healthy living mindsets
It’s hard to miss the heightened shopper interest in health and wellness these days. In our recent “How America Shops” study, The Big Business of WELL, many shoppers showed they are committed to being well: 42% said that while it costs more to “live healthy,” it’s worth it.
Sera Labs: a thriving CBD company with a difference
The retail market for products containing CBD is projected to expand rapidly in the coming years amid the growing acceptance of hemp and cannabis across the country. One of the up-and-coming companies in this category is Sera Labs.
The profit pool for U.S. prescription drugs is shrinking
For the past few years, the United States has been wrestling with the cost of health care. Our system is shifting toward outcomes-based payment models, and falling reimbursements are encouraging efficiency.
CBD’s place in the chain drug merchandise mix
Two thousand eighteen may be remembered in retail marketing history as the year discussing CBD moved from Bon-naroo to the board room. Extensive media coverage; legalization of all forms of cannabis in Canada and parts of the U.S.
A retailer at heart should lead Rite Aid
A new phase in Rite Aid’s two-decade-long quest to fully recover from the criminal financial irregularities that pushed it to the brink of bankruptcy in the late 1990s began last month with top-level management changes and an organizational realignment designed to, in the words of Bruce Bodaken, cha
Mile High Labs raises $65mm to purchase mountains of hemp
Mile High Labs, the largest extractor of CBD in the world, achieved another historic financing event with the close of a $65mm term loan facility, one of the largest non-dilutive capital raises in the sector to date.
Williams appointed CEO at PepsiCo Foods North America
PepsiCo Friday announced that Steven Williams, currently senior vice president and chief commercial officer for Frito-Lay’s U.S.
House introduces legislation to bolster consumer health savings
The Consumer Healthcare Products Association (CHPA) applauds the introduction of the Restoring Access to Medication Act.
Irwin Naturals appoints Tim Toll CEO
Earlier this year, Klee Irwin, owner and founder of Irwin Naturals, named Timothy Toll chief executive officer.